semaglutide esophagus Diabetes patients on Ozempic-like drugs more likely to develop gastroesophageal reflux disease Exploring beyond numeric weight loss:

Although both medications belong to the GLP-1 category, they are not identical

Product concentrations also may vary depending on the compounder, and a single compounder may offer multiple concentrations of compounded semaglutide products

What the Authors Reported Semaglutide reduced the risk of a heart attack or stroke at one year compared to sitagliptin

For comprehensive information about expected results over time, see our complete guide to semaglutide weight loss results month by month

These medications help reduce appetite, promote feelings of fullness, and improve insulin secretion, making them effective tools for weight loss and diabetes management